Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 793242, 11 pages
http://dx.doi.org/10.1155/2014/793242
Research Article

Experimental Protection of Diabetic Mice against Lethal P. aeruginosa Infection by Bacteriophage

1Department of Biotechnology, Gulbarga University, Gulbarga, Karnataka 585106, India
2Luqman College of Pharmacy, Gulbarga, Karnataka 585101, India
3Department of Pathology, M. R. Medical College, Gulbarga, Karnataka 585104, India
4Department of Neuromicrobiology, NIMHANS, Bangalore, Karnataka 560 029, India

Received 18 February 2014; Revised 9 April 2014; Accepted 9 May 2014; Published 5 June 2014

Academic Editor: Ranadhir Chakraborty

Copyright © 2014 Nagaveni Shivshetty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Livermore, “Of Pseudomonas, porins, pumps and carbapenems,” Journal of Antimicrobial Chemotherapy, vol. 47, no. 3, pp. 247–250, 2001. View at Google Scholar · View at Scopus
  2. N. Woodford, J. F. Turton, and D. M. Livermore, “Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance,” FEMS Microbiology Reviews, vol. 35, no. 5, pp. 736–755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Wheat, D. A. Stephen, H. Marietta et al., “Diabetic foot infections bacteriologic analysis,” Archives of Internal Medicine, vol. 146, no. 10, pp. 1935–1940, 1986. View at Google Scholar
  4. N. Joshi, G. M. Caputo, M. R. Weitekamp, and A. W. Karchmer, “Infections in patients with diabetes mellitus,” New England Journal of Medicine, vol. 341, no. 25, pp. 1906–1912, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Międzybrodzki, J. Borysowski, B. Weber-Dąbrowska et al., “Clinical aspects of phage therapy,” Advances in Virus Research, vol. 83, pp. 73–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Biswas, S. Adhya, P. Washart et al., “Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium,” Infection and Immunity, vol. 70, no. 1, pp. 204–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. E. N. Carvalho, N. A. Carvalho, and L. M. Ferreira, “Experimental model of induction of diabetes mellitus in rats,” Acta Cirurgica Brasileira, vol. 18, 2003. View at Google Scholar
  8. C. R. Merril, B. Biswas, R. Carlton et al., “Long-circulating bacteriophage as antibacterial agents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 8, pp. 3188–3192, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. H. W. Smith and M. B. Huggins, “Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics,” Journal of General Microbiology, vol. 128, no. 2, pp. 307–318, 1982. View at Google Scholar · View at Scopus
  10. T. A. Brans, R. P. Dutrieux, M. J. Hoekstra, R. W. Kreis, and J. S. Du Pont, “Histopathological evaluation of scalds and contact burns in the pig model,” Burns, vol. 20, no. 1, pp. S48–S51, 1994. View at Google Scholar · View at Scopus
  11. S. Chugani and E. P. Greenberg, “The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression,” Microbial Pathogenesis, vol. 42, no. 1, pp. 29–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. T. James, “Infectious complications in patients with diabetes mellitus,” International Diabetes Monitor, vol. 12, pp. 1–7, 2000. View at Google Scholar
  13. A. A. Like and A. A. Rossini, “Streptozotocin induced pancreatic insulitis: new model of diabetes mellitus,” Science, vol. 193, no. 4251, pp. 415–417, 1976. View at Google Scholar · View at Scopus
  14. D. J. Leehey, A. K. Singh, J. P. Bast, P. Sethupathi, and R. Singh, “Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats,” Translational Research, vol. 151, no. 4, pp. 208–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Rich and J. C. Lee, “The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse,” Diabetes, vol. 54, no. 10, pp. 2904–2910, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Park, J. Rich, F. Hanses, and J. C. Lee, “Defects in innate immunity predispose C57BL/6J-Lepr db/Lepr db Mice to infection by Staphylococcus aureus,” Infection and Immunity, vol. 77, no. 3, pp. 1008–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Gadepalli, B. Dhawan, V. Sreenivas, A. Kapil, A. C. Ammini, and R. Chaudhry, “A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital,” Diabetes Care, vol. 29, no. 8, pp. 1727–1732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Stone, “Bacteriophage therapy. Stalin's forgotten cure,” Science, vol. 298, no. 5594, pp. 728–731, 2002. View at Google Scholar · View at Scopus
  19. A. Bruttin and H. Brüssow, “Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 7, pp. 2874–2878, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Matsuzaki, M. Yasuda, H. Nishikawa et al., “Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage φMR11,” Journal of Infectious Diseases, vol. 187, no. 4, pp. 613–624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Soothill, “Treatment of experimental infections of mice with bacteriophages,” Journal of Medical Microbiology, vol. 37, no. 4, pp. 258–261, 1992. View at Google Scholar · View at Scopus
  22. G. D. Wright, “Bacterial resistance to antibiotics: enzymatic degradation and modification,” Advanced Drug Delivery Reviews, vol. 57, no. 10, pp. 1451–1470, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Merabishvili, J.-P. Pirnay, G. Verbeken et al., “Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials,” PLoS ONE, vol. 4, no. 3, Article ID e4944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Denou, A. Bruttin, C. Barretto, C. Ngom-Bru, H. Brüssow, and S. Zuber, “T4 phages against Escherichia coli diarrhea: potential and problems,” Virology, vol. 388, no. 1, pp. 21–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-W. Ackermann, “Frequency of morphological phage descriptions in the year 2000,” Archives of Virology, vol. 146, no. 5, pp. 843–857, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Wang, B. Hu, M. Xu et al., “Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa,” International Journal of Molecular Medicine, vol. 17, no. 2, pp. 309–317, 2006. View at Google Scholar · View at Scopus
  27. S. Hagens and M. J. Loessner, “Application of bacteriophages for detection and control of foodborne pathogens,” Applied Microbiology and Biotechnology, vol. 76, no. 3, pp. 513–519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Sunagar, S. A. Patil, and R. K. Chandrakanth, “Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice,” Research in Microbiology, vol. 161, no. 10, pp. 854–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Morello, E. Saussereau, D. Maura, M. Huerre, L. Touqui, and L. Debarbieux, “Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention,” PLoS ONE, vol. 6, no. 2, Article ID e16963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Kurzepa-Skaradzinska, M. Lusiak-Szelachowska, G. Skaradzinski et al., “Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro,” Viral Immunology, vol. 26, no. 2, pp. 150–162, 2013. View at Publisher · View at Google Scholar · View at Scopus